Neurocrine Biosciences
NBIX
#1286
Rank
$13.67 B
Marketcap
$137.45
Share price
-0.28%
Change (1 day)
41.63%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

EPS for Neurocrine Biosciences (NBIX)

EPS in 2023 (TTM): $1.96

According to Neurocrine Biosciences 's latest financial reports the company's current EPS (TTM) is $1.96. In 2022 the company made an earnings per share (EPS) of $1.61 an increase over its 2021 EPS that were of $0.95.

EPS history for Neurocrine Biosciences from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$1.9621.74%
2022$1.6169.47%
2021$0.95-78.21%
2020$4.36990%
2019$0.4081.82%
2018$0.22-113.5%
2017-$1.630.62%
2016-$1.6257.28%
2015-$1.0325.61%
2014-$0.8218.84%
2013-$0.69-1085.71%
2012$0.07000-89.71%
2011$0.68-500%
2010-$0.17-86.92%
2009-$1.30-43.48%
2008-$2.30-57.8%
2007-$5.4592.58%
2006-$2.83371.67%
2005-$0.60-52.76%
2004-$1.2736.56%
2003-$0.93-70%
2002-$3.10118.31%
2001-$1.42

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.86-5.10%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.68 87.79%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.43 177.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.09 6.63%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.03-254.59%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.47-123.98%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.96-251.02%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.55-71.94%๐Ÿ‡ฌ๐Ÿ‡ง UK